• Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Stem Cell Therapeutics Corp

+ Add to Watchlist


0.3350 CAD 0.0100 2.90%

As of 15:50:02 ET on 04/17/2014.

Snapshot for Stem Cell Therapeutics Corp (SSS)

Open: 0.3500 Day's Range: 0.3350 - 0.3500 Volume: 120,230
Previous Close: 0.3450 52wk Range: 0.1400 - 0.7400 1-Yr Rtn: +86.11%

Stock Chart for SSS

No chart data available.
  • SSS:CN 0.3950
  • 1D
  • 1M
  • 1Y
Interactive SSS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SSS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPTSX -
Earnings Per Share (ttm) -0.1000
Est. EPS -
Est. PEG Ratio -
Market Cap (M CAD) 67.76
Shares Outstanding (M) 202.26
30 Day Average Volume 333,895
Price/Book (mrq) 3.7639
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SSS

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for SSS

Stem Cell Therapeutics Corp. is developing its technology platform and intellectual property to selectively induce a patient's own stem cells to proliferate in the brain. The Company is seeking to further develop its technology to create specific disease treatments for stroke, Huntington's disease, Alzheimer's disease, and other neurodegenerative conditions.

Niclas StiernholmPresident/CEOJames T ParsonsChief Financial Officer
More Company Profile & Key Executives for SSS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil